| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000050 | Urea cycle | Increases phenotype | PMID:30980911 |
| GO:0000104 | Succinate dehydrogenase activity | Decreases phenotype | PMID:27236077 |
| GO:0000266 | Mitochondrial fission | Increases phenotype | PMID:31874198 |
| GO:0000422 | Autophagy of mitochondrion | Increases phenotype | PMID:25031709 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:26078282 |
| GO:0000902 | Cell morphogenesis | Affects phenotype | PMID:32142724 |
| GO:0001755 | Neural crest cell migration | Decreases phenotype | PMID:26238599 |
| GO:0001774 | Microglial cell activation | Increases phenotype | PMID:36308466 |
| GO:0001808 | Negative regulation of type iv hypersensitivity | Increases phenotype | PMID:23058909 |
| GO:0001836 | Release of cytochrome c from mitochondria | Affects phenotype | PMID:31874198 |
| GO:0001991 | Regulation of systemic arterial blood pressure by circulatory renin-angiotensin | Increases phenotype | PMID:21494558 |
| GO:0002441 | Histamine secretion involved in inflammatory response | Increases phenotype | PMID:23928832 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:32116774; PMID:38180308 |
| GO:0002575 | Basophil chemotaxis | Increases phenotype | PMID:23088908; PMID:23928832 |
| GO:0002639 | Positive regulation of immunoglobulin production | Increases phenotype | PMID:23928832 |
| GO:0002690 | Positive regulation of leukocyte chemotaxis | Increases phenotype | PMID:22581110 |
| GO:0002693 | Positive regulation of cellular extravasation | Increases phenotype | PMID:28817314 |
| GO:0003084 | Positive regulation of systemic arterial blood pressure | Increases phenotype | PMID:21494558 |
| GO:0003872 | 6-phosphofructokinase activity | Decreases phenotype | PMID:30980912; PMID:34508822 |
| GO:0003954 | Nadh dehydrogenase activity | Decreases phenotype | PMID:32407874 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:35307918 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:35307918 |
| GO:0004129 | Cytochrome-c oxidase activity | Affects phenotype | PMID:39547369 |
| GO:0004303 | Estradiol 17-beta-dehydrogenase activity | Decreases phenotype | PMID:30510688 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:19263481; PMID:25322819; PMID:28817314; PMID:31610155 |
| GO:0004396 | Hexokinase activity | Decreases phenotype | PMID:30980912 |
| GO:0004457 | Lactate dehydrogenase activity | Decreases phenotype | PMID:30615929; PMID:34508822 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:19263481; PMID:19263481; PMID:25322819; PMID:23906897; PMID:24184865; PMID:25322819; PMID:25800560; PMID:30510688; PMID:30510688; PMID:37471654; PMID:32116774; PMID:32407874; PMID:37471654 |
| GO:0004697 | Protein kinase c activity | Decreases phenotype | PMID:31843630 |
| GO:0004722 | Protein serine/threonine phosphatase activity | Increases phenotype | PMID:24954411 |
| GO:0004743 | Pyruvate kinase activity | Decreases phenotype | PMID:30980912 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:24184865; PMID:25322819; PMID:25322819; PMID:30703413; PMID:25800560; PMID:30510688; PMID:30510688; PMID:37471654; PMID:30703413; PMID:31874198; PMID:32116774; PMID:35398025; PMID:35752206; PMID:37471654; PMID:40010429 |
| GO:0005243 | Gap junction channel activity | Decreases phenotype | PMID:33242459 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:31874198 |
| GO:0005757 | Mitochondrial permeability transition pore complex | Affects phenotype | PMID:31874198; PMID:35300571 |
| GO:0005776 | Autophagosome | Affects phenotype | PMID:36840722 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:34508822 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:34508822 |
| GO:0006090 | Pyruvate metabolic process | Affects phenotype | PMID:34508822 |
| GO:0006096 | Glycolytic process | Decreases phenotype | PMID:36096218 |
| GO:0006119 | Oxidative phosphorylation | Decreases phenotype | PMID:36096218; PMID:39547369 |
| GO:0006121 | Mitochondrial electron transport, succinate to ubiquinone | Decreases phenotype | PMID:22534743 |
| GO:0006264 | Mitochondrial dna replication | Decreases phenotype | PMID:31874198 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:28817314; PMID:34553816 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:25530354 |
| GO:0006325 | Chromatin organization | Decreases phenotype | PMID:30905827 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:33242459 |
| GO:0006602 | Creatinine catabolic process | Increases phenotype | PMID:27599793 |
| GO:0006606 | Protein import into nucleus | Increases phenotype | PMID:33080273 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:38180308 |
| GO:0006695 | Cholesterol biosynthetic process | Decreases phenotype | PMID:29908845 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:22197700; PMID:23274417; PMID:23274417; PMID:37471654; PMID:23292317; PMID:23292317; PMID:23428833; PMID:23428833; PMID:24970117; PMID:30251767; PMID:30623991; PMID:32208856; PMID:32407874; PMID:34051273; PMID:34508822; PMID:35307918; PMID:35527006; PMID:35752206; PMID:36088639; PMID:36642386; PMID:37471654; PMID:39032614; PMID:39276841; PMID:40010429 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:24184865; PMID:25322819; PMID:30476502; PMID:30980911; PMID:31874198 |
| GO:0006751 | Glutathione catabolic process | Increases phenotype | PMID:25496357 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:27236077; PMID:31874198; PMID:32407874 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:30980911 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:31843630; PMID:39153536 |
| GO:0006878 | Cellular copper ion homeostasis | Affects phenotype | PMID:40010429 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:39276841 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:29660402 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:24293362; PMID:24960054; PMID:25031709; PMID:25800560; PMID:26498409; PMID:26498409; PMID:26542248; PMID:26542248; PMID:26797587; PMID:27236077; PMID:27604105; PMID:28283887; PMID:30905827; PMID:31874198; PMID:33242459; PMID:40010429 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:31874198 |
| GO:0006939 | Smooth muscle contraction | Increases phenotype | PMID:35498220 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:22728154; PMID:22728154; PMID:30980911 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:32142724; PMID:34508822 |
| GO:0006997 | Nucleus organization | Decreases phenotype | PMID:30905827 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:27236077; PMID:30905827; PMID:31874198; PMID:36642386; PMID:39276841; PMID:39547369 |
| GO:0007029 | Endoplasmic reticulum organization | Decreases phenotype | PMID:30905827 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:38157908; PMID:38180308 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:21712424 |
| GO:0007268 | Chemical synaptic transmission | Affects phenotype | PMID:30121340; PMID:31785328 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:22806249; PMID:30510688; PMID:30510688; PMID:34051273; PMID:31054310; PMID:32142724; PMID:34051273; PMID:34508822; PMID:36484981; PMID:36807407 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:36088639 |
| GO:0007409 | Axonogenesis | Decreases phenotype | PMID:36096218 |
| GO:0007610 | Behavior | Affects phenotype | PMID:32073883 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:27936013; PMID:27936013; PMID:29476096; PMID:30523571; PMID:32058320 |
| GO:0007612 | Learning | Decreases phenotype | PMID:33978298; PMID:36308466; PMID:36539177; PMID:39947421 |
| GO:0007613 | Memory | Decreases phenotype | PMID:28173832; PMID:33978298; PMID:33978298; PMID:35367965; PMID:36539177; PMID:36652739; PMID:39947421 |
| GO:0007626 | Locomotory behavior | Increases phenotype | PMID:35527006 |
| GO:0008021 | Synaptic vesicle | Decreases phenotype | PMID:30121340 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Affects phenotype | PMID:39547369 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:33856607 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:32791093 |
| GO:0008219 | Cell death | Increases phenotype | PMID:24530660; PMID:25975991; PMID:26498409; PMID:26797587; PMID:26865462; PMID:26926986; PMID:29502740; PMID:31708536 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:22806249; PMID:24316150; PMID:24598511; PMID:24962574; PMID:25800560 |
| GO:0008284 | Positive regulation of cell population proliferation | Decreases phenotype | PMID:24200059 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:22101983; PMID:22271317; PMID:23598043; PMID:33932463; PMID:37436718; PMID:37939567 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:30510688 |
| GO:0010035 | Response to inorganic substance | Increases phenotype | PMID:34553816 |
| GO:0010259 | Multicellular organism aging | Affects phenotype | PMID:22613225 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:29481626 |
| GO:0010460 | Positive regulation of heart rate | Increases phenotype | PMID:29457680 |
| GO:0010468 | Regulation of gene expression | Affects phenotype | PMID:32458983 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:32879255; PMID:36652739; PMID:38072110 |
| GO:0010669 | Epithelial structure maintenance | Decreases phenotype | PMID:31054310; PMID:34051273 |
| GO:0010714 | Positive regulation of collagen metabolic process | Increases phenotype | PMID:20643234 |
| GO:0010757 | Negative regulation of plasminogen activation | Affects phenotype | PMID:2143947 |
| GO:0010863 | Positive regulation of phospholipase c activity | Decreases phenotype | PMID:21712424 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:36088639 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:25981801 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:22033380; PMID:25981801; PMID:34051273; PMID:37939567 |
| GO:0010996 | Response to auditory stimulus | Decreases phenotype | PMID:12062763 |
| GO:0014043 | Negative regulation of neuron maturation | Increases phenotype | PMID:28173832 |
| GO:0014069 | Postsynaptic density | Decreases phenotype | PMID:30121340 |
| GO:0015692 | Lead ion transport | Increases phenotype | PMID:34051273; PMID:34508822 |
| GO:0015723 | Bilirubin transport | Increases phenotype | PMID:30251767 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:22728154; PMID:22728154; PMID:30980911; PMID:24293362; PMID:25322819; PMID:25322819; PMID:30703413; PMID:25800560; PMID:30510688; PMID:30703413; PMID:30980911; PMID:31610155; PMID:31874198; PMID:32407874; PMID:34508822; PMID:35307918; PMID:35398025; PMID:35752206 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:30615929 |
| GO:0016209 | Antioxidant activity | Decreases phenotype | PMID:37385299 |
| GO:0016358 | Dendrite development | Decreases phenotype | PMID:31708536 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:38157908 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:23292317; PMID:23501611; PMID:25322819; PMID:30251767; PMID:32407874; PMID:36088639; PMID:36484981 |
| GO:0019249 | Lactate biosynthetic process | Decreases phenotype | PMID:30615929 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:32116774 |
| GO:0019827 | Stem cell population maintenance | Decreases phenotype | PMID:31715224 |
| GO:0020027 | Hemoglobin metabolic process | Affects phenotype | PMID:22534743 |
| GO:0021778 | Oligodendrocyte cell fate specification | Increases phenotype | PMID:32458983 |
| GO:0022008 | Neurogenesis | Decreases phenotype | PMID:33978298 |
| GO:0022010 | Central nervous system myelination | Decreases phenotype | PMID:39150886 |
| GO:0030097 | Hemopoiesis | Decreases phenotype | PMID:25800560 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:36096218 |
| GO:0030263 | Apoptotic chromosome condensation | Affects phenotype | PMID:30905827; PMID:31708536; PMID:32116774; PMID:32208856; PMID:38180308 |
| GO:0030317 | Flagellated sperm motility | Decreases phenotype | PMID:31054310 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:39722890 |
| GO:0030336 | Negative regulation of cell migration | Increases phenotype | PMID:38281554 |
| GO:0030500 | Regulation of bone mineralization | Decreases phenotype | PMID:27915097 |
| GO:0030501 | Positive regulation of bone mineralization | Decreases phenotype | PMID:20643234 |
| GO:0030730 | Sequestering of triglyceride | Increases phenotype | PMID:34842334 |
| GO:0031175 | Neuron projection development | Affects phenotype | PMID:33080273; PMID:39947421 |
| GO:0031987 | Locomotion involved in locomotory behavior | Affects phenotype | PMID:25322819; PMID:35398025 |
| GO:0032008 | Positive regulation of tor signaling | Decreases phenotype | PMID:22811615 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:29502740 |
| GO:0032148 | Activation of protein kinase b activity | Decreases phenotype | PMID:23501611; PMID:23501611; PMID:23855546; PMID:23855546; PMID:32879255 |
| GO:0032286 | Central nervous system myelin maintenance | Decreases phenotype | PMID:23680456 |
| GO:0032430 | Positive regulation of phospholipase a2 activity | Increases phenotype | PMID:23030477 |
| GO:0032469 | Endoplasmic reticulum calcium ion homeostasis | Affects phenotype | PMID:36308466 |
| GO:0032516 | Positive regulation of phosphoprotein phosphatase activity | Increases phenotype | PMID:21195594 |
| GO:0032715 | Negative regulation of interleukin-6 production | Affects phenotype | PMID:23598043 |
| GO:0032776 | Dna methylation on cytosine | Affects phenotype | PMID:33445541 |
| GO:0032790 | Ribosome disassembly | Increases phenotype | PMID:30905827 |
| GO:0034101 | Erythrocyte homeostasis | Affects phenotype | PMID:22534743 |
| GO:0034199 | Activation of protein kinase a activity | Decreases phenotype | PMID:23855546 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:22033380; PMID:22197700; PMID:22197700; PMID:23086308; PMID:22534743; PMID:22894711; PMID:23292317; PMID:23292317; PMID:23501611; PMID:23855546; PMID:35527006; PMID:23292317; PMID:30623991; PMID:23501611; PMID:23855546; PMID:24222729; PMID:24222729; PMID:24970117; PMID:24970117; PMID:25088297; PMID:25088297; PMID:27492863; PMID:27492863; PMID:28817314; PMID:28817314; PMID:30251767; PMID:30251767; PMID:30623991; PMID:31054310; PMID:31054310; PMID:34051273; PMID:37471654; PMID:32879255; PMID:34051273; PMID:34553816; PMID:35527006; PMID:36088639; PMID:36484981; PMID:36642386; PMID:37471654; PMID:39276841; PMID:40010429 |
| GO:0034599 | Cellular response to oxidative stress | Increases phenotype | PMID:32058320 |
| GO:0035633 | Maintenance of blood-brain barrier | Decreases phenotype | PMID:24200059 |
| GO:0035640 | Exploration behavior | Affects phenotype | PMID:36539177 |
| GO:0035902 | Response to immobilization stress | Affects phenotype | PMID:32073883 |
| GO:0040015 | Negative regulation of multicellular organism growth | Increases phenotype | PMID:34553816; PMID:36088639 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:32791093 |
| GO:0042311 | Vasodilation | Increases phenotype | PMID:23760256 |
| GO:0042332 | Gravitaxis | Decreases phenotype | PMID:30510688 |
| GO:0042416 | Dopamine biosynthetic process | Affects phenotype | PMID:25322819; PMID:2604901 |
| GO:0042421 | Norepinephrine biosynthetic process | Increases phenotype | PMID:2604901 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:25800560; PMID:30510688; PMID:35398025 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:30251767 |
| GO:0042670 | Retinal cone cell differentiation | Decreases phenotype | PMID:28050121 |
| GO:0042755 | Eating behavior | Affects phenotype | PMID:33862172 |
| GO:0042756 | Drinking behavior | Increases phenotype | PMID:31550440; PMID:33862172 |
| GO:0043005 | Neuron projection | Decreases phenotype | PMID:33080273 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:21640820; PMID:21712424; PMID:22033380; PMID:22811615; PMID:23086308; PMID:24806610; PMID:22952811; PMID:23428833; PMID:23680456; PMID:27492863; PMID:29797346; PMID:37866543; PMID:38072110 |
| GO:0043197 | Dendritic spine | Affects phenotype | PMID:39947421 |
| GO:0043371 | Negative regulation of cd4-positive, alpha-beta t cell differentiation | Increases phenotype | PMID:23058909 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:33445541 |
| GO:0044237 | Cellular metabolic process | Affects phenotype | PMID:30476502; PMID:31610155; PMID:31715224; PMID:31843630; PMID:31874198; PMID:31874198; PMID:35300571; PMID:39032614; PMID:39547369; PMID:32142724; PMID:34508822; PMID:32344020; PMID:32344020; PMID:39947421; PMID:34508822; PMID:35300571; PMID:36484981; PMID:36642386; PMID:36925031; PMID:38157908; PMID:39032614; PMID:39276841; PMID:39547369; PMID:40010429 |
| GO:0044728 | Dna methylation or demethylation | Affects phenotype | PMID:33445541 |
| GO:0044838 | Cell quiescence | Increases phenotype | PMID:37436718 |
| GO:0044861 | Protein transport into plasma membrane raft | Increases phenotype | PMID:22033380 |
| GO:0045216 | Cell-cell junction organization | Decreases phenotype | PMID:36642386 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Affects phenotype | PMID:23501611; PMID:23501611; PMID:23855546; PMID:23855546; PMID:30251767 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:22033380; PMID:34553816; PMID:36088639 |
| GO:0045591 | Positive regulation of regulatory t cell differentiation | Increases phenotype | PMID:23058909 |
| GO:0045662 | Negative regulation of myoblast differentiation | Increases phenotype | PMID:37797690 |
| GO:0045665 | Negative regulation of neuron differentiation | Increases phenotype | PMID:28173832 |
| GO:0045777 | Positive regulation of blood pressure | Increases phenotype | PMID:29457680 |
| GO:0045792 | Negative regulation of cell size | Increases phenotype | PMID:22033380 |
| GO:0045852 | Ph elevation | Increases phenotype | PMID:34842334 |
| GO:0045907 | Positive regulation of vasoconstriction | Increases phenotype | PMID:23760256 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:24782466; PMID:25800560 |
| GO:0045987 | Positive regulation of smooth muscle contraction | Increases phenotype | PMID:23088908; PMID:23928832 |
| GO:0046034 | Atp metabolic process | Increases phenotype | PMID:29797346; PMID:34508822; PMID:36088639; PMID:36484981; PMID:39547369 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:32791093; PMID:35752206 |
| GO:0046323 | Glucose import | Decreases phenotype | PMID:31874198 |
| GO:0046330 | Positive regulation of jnk cascade | Increases phenotype | PMID:24200059; PMID:24481447; PMID:25088297 |
| GO:0046415 | Urate metabolic process | Affects phenotype | PMID:23428833 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:23428833; PMID:30980911; PMID:30980911; PMID:32116774; PMID:32116774 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:25496357 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:30623991; PMID:31054310; PMID:36088639 |
| GO:0046622 | Positive regulation of organ growth | Affects phenotype | PMID:27492863; PMID:34553816 |
| GO:0046722 | Lactic acid secretion | Decreases phenotype | PMID:30615929 |
| GO:0046850 | Regulation of bone remodeling | Decreases phenotype | PMID:27915097 |
| GO:0046852 | Positive regulation of bone remodeling | Increases phenotype | PMID:20643234 |
| GO:0046933 | Proton-transporting atp synthase activity, rotational mechanism | Decreases phenotype | PMID:39547369 |
| GO:0048143 | Astrocyte activation | Increases phenotype | PMID:26396915 |
| GO:0048149 | Behavioral response to ethanol | Increases phenotype | PMID:30385389 |
| GO:0048642 | Negative regulation of skeletal muscle tissue development | Increases phenotype | PMID:37797690 |
| GO:0048714 | Positive regulation of oligodendrocyte differentiation | Increases phenotype | PMID:32458983 |
| GO:0048863 | Stem cell differentiation | Affects phenotype | PMID:31715224 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:30510688 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:37385299; PMID:38530053 |
| GO:0050768 | Negative regulation of neurogenesis | Increases phenotype | PMID:28173832 |
| GO:0050807 | Regulation of synapse organization | Decreases phenotype | PMID:24806610 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:19647414; PMID:30523571; PMID:38530053 |
| GO:0051346 | Negative regulation of hydrolase activity | Affects phenotype | PMID:28817314 |
| GO:0051348 | Negative regulation of transferase activity | Affects phenotype | PMID:28817314 |
| GO:0051354 | Negative regulation of oxidoreductase activity | Increases phenotype | PMID:36088639 |
| GO:0051402 | Neuron apoptotic process | Increases phenotype | PMID:33978298 |
| GO:0051560 | Mitochondrial calcium ion homeostasis | Affects phenotype | PMID:36308466 |
| GO:0051611 | Regulation of serotonin uptake | Decreases phenotype | PMID:27771255 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Decreases phenotype | PMID:25800560; PMID:26542248; PMID:29660402; PMID:31874198; PMID:32407874; PMID:35300571 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:36484981 |
| GO:0051897 | Positive regulation of protein kinase b signaling | Affects phenotype | PMID:22811615; PMID:23501611; PMID:24200059 |
| GO:0051964 | Negative regulation of synapse assembly | Increases phenotype | PMID:27771255; PMID:28050121 |
| GO:0051965 | Positive regulation of synapse assembly | Decreases phenotype | PMID:24999626 |
| GO:0052689 | Carboxylic ester hydrolase activity | Decreases phenotype | PMID:28817314 |
| GO:0055065 | Metal ion homeostasis | Decreases phenotype | PMID:29452138; PMID:32208856 |
| GO:0055069 | Zinc ion homeostasis | Affects phenotype | PMID:35398025 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:30905827 |
| GO:0060013 | Righting reflex | Decreases phenotype | PMID:30510688 |
| GO:0060080 | Inhibitory postsynaptic potential | Affects phenotype | PMID:30121340 |
| GO:0060193 | Positive regulation of lipase activity | Increases phenotype | PMID:30251767 |
| GO:0060221 | Retinal rod cell differentiation | Decreases phenotype | PMID:28050121 |
| GO:0060587 | Regulation of lipoprotein lipid oxidation | Increases phenotype | PMID:23428833 |
| GO:0060588 | Negative regulation of lipoprotein lipid oxidation | Increases phenotype | PMID:23428833 |
| GO:0060996 | Dendritic spine development | Decreases phenotype | PMID:27936013; PMID:39947421 |
| GO:0061000 | Negative regulation of dendritic spine development | Increases phenotype | PMID:29476096 |
| GO:0061075 | Positive regulation of neural retina development | Decreases phenotype | PMID:23680456 |
| GO:0061351 | Neural precursor cell proliferation | Decreases phenotype | PMID:27562236 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:22806249; PMID:30510688; PMID:36484981; PMID:36807407 |
| GO:0061564 | Axon development | Decreases phenotype | PMID:23680456 |
| GO:0061739 | Protein lipidation involved in autophagosome assembly | Increases phenotype | PMID:32879255; PMID:34842334 |
| GO:0061890 | Positive regulation of astrocyte activation | Increases phenotype | PMID:32879255 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:38180308 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:30251767 |
| GO:0070374 | Positive regulation of erk1 and erk2 cascade | Increases phenotype | PMID:24200059; PMID:24481447 |
| GO:0070444 | Oligodendrocyte progenitor proliferation | Decreases phenotype | PMID:39150886 |
| GO:0070814 | Hydrogen sulfide biosynthetic process | Decreases phenotype | PMID:30980911 |
| GO:0070977 | Bone maturation | Decreases phenotype | PMID:24959776 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:24184865; PMID:24293362; PMID:32116774; PMID:32208856; PMID:35398025; PMID:36484981; PMID:36807407; PMID:36807407; PMID:37471654; PMID:37471654; PMID:38180308; PMID:39547369 |
| GO:0070997 | Neuron death | Increases phenotype | PMID:36308466 |
| GO:0071284 | Cellular response to lead ion | Increases phenotype | PMID:22839698; PMID:32458983 |
| GO:0071577 | Zinc ion transmembrane transport | Increases phenotype | PMID:24311739 |
| GO:0071763 | Nuclear membrane organization | Decreases phenotype | PMID:30905827 |
| GO:0071971 | Extracellular exosome assembly | Increases phenotype | PMID:36840722 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:24412756; PMID:25800560; PMID:32407874; PMID:35300571; PMID:36642386; PMID:39032614; PMID:39276841; PMID:40010429 |
| GO:0090090 | Negative regulation of canonical wnt signaling pathway | Increases phenotype | PMID:37436718 |
| GO:0090263 | Positive regulation of canonical wnt signaling pathway | Decreases phenotype | PMID:24999626 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Decreases phenotype | PMID:27492863 |
| GO:0090398 | Cellular senescence | Increases phenotype | PMID:25800560 |
| GO:0090648 | Response to environmental enrichment | Decreases phenotype | PMID:35398025 |
| GO:0097062 | Dendritic spine maintenance | Decreases phenotype | PMID:30738087 |
| GO:0097119 | Postsynaptic density protein 95 clustering | Decreases phenotype | PMID:26660114 |
| GO:0097150 | Neuronal stem cell population maintenance | Decreases phenotype | PMID:22812564 |
| GO:0097410 | Hippocampal interneuron differentiation | Affects phenotype | PMID:33862172 |
| GO:0097621 | Monoamine oxidase activity | Decreases phenotype | PMID:19647414 |
| GO:0097707 | Ferroptosis | Increases phenotype | PMID:36642386 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:30510688; PMID:36484981; PMID:36807407 |
| GO:0098743 | Cell aggregation | Decreases phenotype | PMID:24260418 |
| GO:0098816 | Mini excitatory postsynaptic potential | Affects phenotype | PMID:30121340 |
| GO:0099558 | Maintenance of synapse structure | Decreases phenotype | PMID:27984133 |
| GO:0099610 | Action potential initiation | Decreases phenotype | PMID:12062763 |
| GO:0102727 | 3beta-hydroxysteroid dehydrogenase activity | Decreases phenotype | PMID:30510688 |
| GO:0106128 | Negative regulation of store-operated calcium entry | Increases phenotype | PMID:38281554 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:34842334 |
| GO:0140657 | Atp-dependent activity | Decreases phenotype | PMID:35307918 |
| GO:0150195 | Transport across blood-cerebrospinal fluid barrier | Affects phenotype | PMID:36642386 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:26396915 |
| GO:1900154 | Regulation of bone trabecula formation | Decreases phenotype | PMID:27915097 |
| GO:1900181 | Negative regulation of protein localization to nucleus | Increases phenotype | PMID:34842334; PMID:35527006 |
| GO:1900272 | Negative regulation of long-term synaptic potentiation | Increases phenotype | PMID:22952811; PMID:29476096 |
| GO:1900409 | Positive regulation of cellular response to oxidative stress | Increases phenotype | PMID:29797346 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:24200059; PMID:25088297; PMID:26396915; PMID:29457680 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:18353414 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Increases phenotype | PMID:34051273; PMID:36088639 |
| GO:1901612 | Cardiolipin binding | Decreases phenotype | PMID:35300571 |
| GO:1901668 | Regulation of superoxide dismutase activity | Affects phenotype | PMID:30251767 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:19647414; PMID:23428833; PMID:29797346; PMID:31054310; PMID:31054310; PMID:34051273; PMID:34051273; PMID:35527006 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Affects phenotype | PMID:23086308; PMID:24222729; PMID:24970117; PMID:24970117; PMID:30623991 |
| GO:1901687 | Glutathione derivative biosynthetic process | Affects phenotype | PMID:22033380; PMID:23274417 |
| GO:1901740 | Negative regulation of myoblast fusion | Increases phenotype | PMID:37797690 |
| GO:1902043 | Positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | Increases phenotype | PMID:22033380 |
| GO:1902046 | Positive regulation of fas signaling pathway | Increases phenotype | PMID:22033380 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:22894711; PMID:26396915 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:19647414 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:29502740 |
| GO:1903282 | Regulation of glutathione peroxidase activity | Affects phenotype | PMID:30251767 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:30623991; PMID:31054310 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Affects phenotype | PMID:22033380; PMID:22197700; PMID:22534743; PMID:24222729; PMID:24970117 |
| GO:1903408 | Positive regulation of p-type sodium:potassium-exchanging transporter activity | Increases phenotype | PMID:21494558 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:22728154; PMID:25322819; PMID:26498409; PMID:26498409; PMID:26542248; PMID:26797587; PMID:27236077; PMID:30476502; PMID:30905827; PMID:31610155; PMID:31874198 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:19647414; PMID:19647414; PMID:25088297; PMID:22033380; PMID:22271317; PMID:23086308; PMID:23292317; PMID:23292317; PMID:30623991; PMID:23501611; PMID:23501611; PMID:23855546; PMID:23855546; PMID:24782466; PMID:24970117; PMID:25088297; PMID:27599793; PMID:34051273; PMID:36088639; PMID:36308466; PMID:37385299; PMID:37939567 |
| GO:1903591 | Negative regulation of lysozyme activity | Increases phenotype | PMID:22581110 |
| GO:1903592 | Positive regulation of lysozyme activity | Increases phenotype | PMID:22581110 |
| GO:1903599 | Positive regulation of autophagy of mitochondrion | Increases phenotype | PMID:24806610 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:38530053 |
| GO:1903980 | Positive regulation of microglial cell activation | Increases phenotype | PMID:22952811; PMID:38281554 |
| GO:1904109 | Positive regulation of cholesterol import | Increases phenotype | PMID:34842334 |
| GO:1905037 | Autophagosome organization | Affects phenotype | PMID:36840722 |
| GO:1905075 | Positive regulation of tight junction disassembly | Increases phenotype | PMID:39722890 |
| GO:1905166 | Negative regulation of lysosomal protein catabolic process | Increases phenotype | PMID:34842334 |
| GO:1905456 | Regulation of lymphoid progenitor cell differentiation | Affects phenotype | PMID:32428222 |
| GO:1905672 | Negative regulation of lysosome organization | Increases phenotype | PMID:34842334 |
| GO:1990182 | Exosomal secretion | Increases phenotype | PMID:36840722 |
| GO:2000134 | Negative regulation of g1/s transition of mitotic cell cycle | Increases phenotype | PMID:24782466; PMID:38072110 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:36088639 |
| GO:2000252 | Negative regulation of feeding behavior | Increases phenotype | PMID:32208856 |
| GO:2000304 | Positive regulation of ceramide biosynthetic process | Increases phenotype | PMID:22033380 |
| GO:2000379 | Positive regulation of reactive oxygen species metabolic process | Increases phenotype | PMID:36308466 |
| GO:2000391 | Positive regulation of neutrophil extravasation | Increases phenotype | PMID:23088908; PMID:23928832 |
| GO:2000403 | Positive regulation of lymphocyte migration | Increases phenotype | PMID:23088908; PMID:23928832 |
| GO:2000421 | Positive regulation of eosinophil extravasation | Increases phenotype | PMID:23088908; PMID:23928832 |
| GO:2000439 | Positive regulation of monocyte extravasation | Increases phenotype | PMID:23928832 |
| GO:2000481 | Positive regulation of camp-dependent protein kinase activity | Decreases phenotype | PMID:23501611 |
| GO:2000610 | Negative regulation of thyroid hormone generation | Increases phenotype | PMID:34553816 |
| GO:2000774 | Positive regulation of cellular senescence | Increases phenotype | PMID:24782466 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:22811615; PMID:32879255; PMID:34842334 |
| GO:2000808 | Negative regulation of synaptic vesicle clustering | Increases phenotype | PMID:35367965 |
| GO:2000841 | Negative regulation of dehydroepiandrosterone secretion | Increases phenotype | PMID:30523571 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:31054310; PMID:31054310; PMID:34051273; PMID:34051273; PMID:36088639 |
| GO:2000845 | Positive regulation of testosterone secretion | Decreases phenotype | PMID:25981801 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:31054310 |
| GO:2001057 | Reactive nitrogen species metabolic process | Affects phenotype | PMID:32407874 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.